Literature DB >> 21984245

Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium.

Huanli Liu1, Yuan Gao, Li-Rong Yu, Richard C Jones, Christopher A Elkins, Mark E Hart.   

Abstract

Lactobacillus species are a predominant member of the vaginal microflora and are critical in maintaining an acidic vaginal environment thought to contribute to the prevention of a number of urogenital diseases. However, during menstruation the pH of the vaginal environment increases to neutrality, a pH conducive for Staphylococcus aureus proliferation and the production of toxic shock syndrome toxin 1 (TSST-1) in susceptible women. In order to generate Lactobacillus species capable of expressing lysostaphin (an endopeptidase that cleaves the cell wall of S. aureus) in a modified genital tract secretion medium (mGTS) under neutral-pH conditions, six prominent proteins from Lactobacillus plantarum WCFS1 spent medium were identified by mass spectrometry. Sequences for promoters, signal peptides, and mature lysostaphin were used to construct plasmids that were subsequently transformed into L. plantarum WCFS1. The promoter and signal sequences of Lp_3014 (putatively identified as a transglycosylase) or the promoter sequence of Lp_0789 (putatively identified as glyceraldehyde 3-phosphate dehydrogenase) with the signal sequence of Lp_3014 exhibited lysostaphin activity on buffered medium containing heat-killed S. aureus. The cassettes were integrated into the chromosome of L. plantarum WCFS1, but only the cassette containing the promoter and signal sequence from Lp_3014 had integrated into the appropriate site. Coculture assays using buffered mGTS showed that lysostaphin expressed from L. plantarum WCFS1 reduced the growth of TSST-1-producing strains of S. aureus under neutral-pH conditions. This study provides the basis for determining whether lysostaphin-producing Lactobacillus strains could potentially be used as a means to inhibit the growth of S. aureus during menstruation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984245      PMCID: PMC3233112          DOI: 10.1128/AEM.06755-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  74 in total

Review 1.  Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora.

Authors:  V Redondo-Lopez; R L Cook; J D Sobel
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

2.  The molecular organization of the lysostaphin gene and its sequences repeated in tandem.

Authors:  P Heinrich; R Rosenstein; M Böhmer; P Sonner; F Götz
Journal:  Mol Gen Genet       Date:  1987-10

3.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

4.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

5.  Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans.

Authors:  P A Recsei; A D Gruss; R P Novick
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

6.  Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome.

Authors:  J M Vergeront; S J Stolz; B A Crass; D B Nelson; J P Davis; M S Bergdoll
Journal:  J Infect Dis       Date:  1983-10       Impact factor: 5.226

7.  Active surveillance for toxic shock syndrome in the United States, 1986.

Authors:  S Gaventa; A L Reingold; A W Hightower; C V Broome; B Schwartz; C Hoppe; J Harwell; L K Lefkowitz; S Makintubee; D R Cundiff
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

8.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

9.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

10.  A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome.

Authors:  J M Musser; P M Schlievert; A W Chow; P Ewan; B N Kreiswirth; V T Rosdahl; A S Naidu; W Witte; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

View more
  5 in total

1.  Characterization of a stress tolerance-defective mutant of Lactobacillus rhamnosus LRB.

Authors:  Saswati Biswas; Andrew Keightley; Indranil Biswas
Journal:  Mol Oral Microbiol       Date:  2019-06-07       Impact factor: 3.563

2.  Association of Vitamin B12, Lactate Dehydrogenase, and Regulation of NF-κB in the Mitigation of Sodium Arsenite-Induced ROS Generation in Uterine Tissue by Commercially Available Probiotics.

Authors:  Sandip Chattopadhyay; Shamima Khatun; Moulima Maity; Suryashis Jana; Hasina Perveen; Moumita Dash; Arindam Dey; Lipi Rani Jana; Pikash Pratim Maity
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

Review 3.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

4.  Colicin E2 Expression in Lactobacillus brevis DT24, A Vaginal Probiotic Isolate, against Uropathogenic Escherichia coli.

Authors:  Disha Trivedi; Prasant Kumar Jena; Sriram Seshadri
Journal:  ISRN Urol       Date:  2014-02-04

5.  Complex ecological interactions of Staphylococcus aureus in tampons during menstruation.

Authors:  Isaline Jacquemond; Anaëlle Muggeo; Gery Lamblin; Anne Tristan; Yves Gillet; Pierre Adrien Bolze; Michèle Bes; Claude Alexandre Gustave; Jean-Philippe Rasigade; François Golfier; Tristan Ferry; Audrey Dubost; Danis Abrouk; Samuel Barreto; Claire Prigent-Combaret; Jean Thioulouse; Gérard Lina; Daniel Muller
Journal:  Sci Rep       Date:  2018-07-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.